CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 17 filers reported holding CALLIDITAS THERAPEUTICS AB in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,835,000 | -78.6% | 62,306 | -80.0% | 0.08% | -73.8% |
| Q1 2021 | $8,574,000 | -18.0% | 311,030 | 0.0% | 0.30% | -35.5% |
| Q4 2020 | $10,457,000 | -24.9% | 311,030 | -46.4% | 0.47% | -41.9% |
| Q3 2020 | $13,920,000 | +3.4% | 580,000 | 0.0% | 0.80% | -16.7% |
| Q2 2020 | $13,456,000 | – | 580,000 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 550,000 | $13,200,000 | 1.69% |
| BVF INC/IL | 750,000 | $18,000,000 | 0.98% |
| Vivo Capital, LLC | 580,000 | $13,920,000 | 0.80% |
| Endurant Capital Management LP | 111,467 | $2,675,000 | 0.79% |
| Burrage Capital Management LLC | 11,034 | $265,000 | 0.21% |
| HHLR ADVISORS, LTD. | 350,000 | $8,400,000 | 0.06% |
| Point72 Asset Management, L.P. | 257,892 | $6,189,000 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 24,422 | $586,000 | 0.02% |
| Pentwater Capital Management LP | 61,084 | $1,466,000 | 0.02% |
| Orbimed Advisors | 17,696 | $425,000 | 0.01% |